Sickle Cell Disease, a severe genetic blood disorder, disproportionately affects India’s tribal population, particularly in the central and eastern regions, where the disease burden is highest. The ...
Held in Paris, France from October 28-31, the iGEM Giant Jamboree is a world expo for synthetic biology. This year’s competition featured 421 teams competing for medals and awards by designing, ...
A single multipurpose gene-editing tool can correct several genetic conditions by restoring proteins that have been truncated ...
Barchart on MSN
This Leading Gene-Editing Stock Could Be Going Private. Should You Buy Its Shares First?
The global cell therapy market was valued at $5.88 billion in 2024 and is on track to hit $44.39 billion by 2034, expanding ...
Learn more about whether Aurinia Pharmaceuticals Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ ...
CRISPR gene-editing technology lets scientists make precise changes to an organism’s DNA. Invented in 2012 by Jennifer Doudna and Emmanuelle Charpentier, biochemists who went on to win the Nobel prize ...
Launching the therapy, Dr. Jitendra Singh declared that India has officially begun its decisive march toward a Sickle ...
CRISPR has turned a simple fungus into a fast-growing, meat-like protein source with impressively low environmental impact.
Hosts David and Gina explore how scientists over the centuries unlocked the ability to edit our genes ...
A slew of new studies and reports suggest that new molecular approaches may soon help reduce the global burden of tuberculosis.
Using CRISPR gene editing technology, researchers from Jiangnan University in China took a fungus that is already used as a ...
In a new study published in Trends in Biotechnology, researchers used a gene-editing technology called CRISPR to increase a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results